Logos Capital portfolio
43 tracked investments, 6 on the map, $3.6B raised across the mapped portfolio.
Logos Capital43 investments · 6 on the map · $3.6B raised- Ocular Therapeutix
- Janux Therapeutics
- Compass Pathways
- SynthegoSeries E
- Mirador TherapeuticsSeries B
- AllakosPost-IPO Equity
Also in the portfolio
- Parse Biosciences
- Willow
- Vigil Neuroscience
- Biomea Fusion
- Rapport Therapeutics
- RayzeBio
- Design Therapeutics
- Dianthus Therapeutics
- Elektrofi
- Angitia Biopharmaceuticals
- Verve Therapeutics
- Boundless Bio
- Enliven Therapeutics
- ProfoundBio
- Repare Therapeutics
- Centessa Pharmaceuticals
- Aligos Therapeutics
- Affinivax
- Attralus
- Vanqua Bio
- Yarrow
- Arvinas
- Simcha Therapeutics
- VistaGen
- ALX Oncology
- Pliant Therapeutics
- DTx Pharma
- Rain Oncology
- Black Diamond Therapeutics
- Akero Therapeutics
- Passage Bio
- Alpine Immune Sciences
- Ikena Oncology
- Delcath Systems
- Viracta Therapeutics
Investors similar to Logos Capital
TCG Crossover27 investments · 9 on the map · $4.1B raised
Surveyor Capital45 investments · 7 on the map · $4B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised
OrbiMed177 investments · 137 on the map · $9.6B raised
Perceptive Advisors109 investments · 13 on the map · $4.4B raised
Biotechnology Value Fund51 investments · 6 on the map · $2.1B raised